Vascular Dynamics, Inc.
7
2
3
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 80/100
28.6%
2 terminated/withdrawn out of 7 trials
50.0%
-36.5% vs industry average
0%
0 trials in Phase 3/4
100%
2 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
CALM- 2 - Controlling and Lowering Blood Pressure With the MobiusHD™
Role: lead
Effect of the MobiusHD® in Patients With Heart Failure
Role: lead
Controlling and Lowering Blood Pressure With The MOBIUS HD™ (CALM-FIM_EUR)
Role: lead
Controlling And Lowering Blood Pressure With the MobiusHDTM Device
Role: lead
Controlling and Lowering Blood Pressure With the MobiusHD™
Role: lead
Effect of the MobiusHD® in Renal Hemodialysis Subjects With Uncontrolled Hypertension
Role: lead
Controlling and Lowering Blood Pressure With The MOBIUSHD™
Role: lead
All 7 trials loaded